10-Q quarterly report · filed Nov 16, 2026

OMEROS CORP (OMER) Q3 2026 10-Q Quarterly Report

Short answer

OMEROS CORP (OMER) filed its Q3 2026 10-Q quarterly report on Nov 16, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $36M with net income of −$57M.

Q3 2026 key financials · XBRL

Revenue
$36M
+26.0% QoQ
Net income
−$57M
−85.5% YoY · −533.5% QoQ
Operating margin
12.5%
EPS (diluted)
−$0.64
−39.1% YoY · −526.7% QoQ

Source: XBRL data from the OMEROS CORP (OMER) Q3 2026 10-Q on SEC EDGAR. USD.

OMEROS CORP Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Q3 revenue $35.9M vs $0 YoY, following YARTEMLEA launch in January 2026
  • Gross margin approximately 100% in Q3, reflecting low-cost pre-approval inventory
  • YARTEMLEA: $35.9M net sales, 109 ordering accounts, up 49% from June 30
  • Cash, equivalents and short-term investments $95.3M; operating cash flow $13.3M
  • Q4 R&D and SG&A expected higher; EU authorization not expected after negative CHMP opinion

Risk Factors

  • New market risk: $100.0 million share repurchase program may increase stock-price volatility
  • Program discretion: repurchases may be suspended or terminated anytime, with $90.1 million remaining November 16, 2026
  • Liquidity risk: repurchases could potentially reduce market liquidity for common stock
  • Valuation risk: stock price may decline below repurchase prices, reducing shareholder value

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other OMEROS CORP quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.